Molly A. Brewer, DVM, MD, MSProfessor of Obstetrics and GynecologyChair, Department of Obstetrics and Gynecology
|
|
Education
Post-Graduate Training
Awards
Degree | Institution | Major |
---|---|---|
BS | Texas A&M University | Biological Sciences |
DVM | Texas A&M University | Veterinary Medicine |
MD | SUNY Health Science Center | Medicine |
MS | University of Michigan School of Public Health | Statistical Analysis and Clinical Research Design |
Post-Graduate Training
Training | Institution | Specialty |
---|---|---|
Fellowship | Memorial Sloan-Kettering Cancer Center | Galloway Fellow |
Residency | Oregon Health Sciences University Hospital | Department of Obstetrics and Gynecology |
Fellowship | University of Texas MD Anderson Cancer Center | Department of Gynecologic Oncology |
Awards
Name of Award/Honor | Awarding Organization |
---|---|
Outstanding Yound Alumna Award | SUNY Syracuse |
Conquer Cancer Foundation of ASCO Grants Selection Committee | |
Senior Academic Promotions Committee | |
John MIlerick Teaching Award Presented by the Fourth Year Obstetric and Gynecology Students | |
Top 5% reviewers for American Journal of Obstetrics and Gynecology | |
Invited to Attend Leadership Development for Physicians in Academic Health Centers | Harvard School of Public Health |
Congressionally Directed Medical Research Programs, Ovarian Cancer Research Program Integration Panel | |
Finalist: Women of Innovation in Connecticut | |
Department of Defense Concept Award, "Ovarian Cancer" | |
Best Doctors in America 2006-2022 | |
Listed in Who's Who in Prevention | Arizona Cancer Center |
Co-Chair of United Engineering Foundation Conference | Banff, Canada |
Dean's Physician-Scientist Career Development Award | University of Arizona |
Dean's Physician-Scientist Career Development Award/Nielsen Award | University of Arizona and Arizona Cancer Center, Tucson, Arizona |
Taskforce on the Treatment of Intraepithelial Neoplasia | AACR, U.S. Food and Drug Administration |
Berlex Foundation Participant | Berlex Foundation |
Hal Lee, M.D. Scholarship Award | Memorial Sloan-Kettering Cancer Center |
Galloway Fellow | Memorial Sloan-Kettering Cancer Center |
Student Award for Exceptional OB/GYN Student | Robert E.L. Nesbitt Jr., M.D. |
Alpha Omega Alpha Honor Society | Alpha Omega Alpha |
Academic Promotions Committee | SUNY |
Honor Society for the Biological Sciences | Texas A&M University |
Dean's List | Texas A&M University |
Name & Description | Category | Role | Type | Scope | Start Year | End Year |
---|---|---|---|---|---|---|
American Gynecologic and Obstetric Society | Professional/Scientific Organization | Member | External | National | 2009 | |
Cancer Center Research Cabinet Committee | Research Committee | Member | External | State | 2006 | 2006 |
Special Emphasis Panel (SEP) for review of applications submitted to the National Cancer Institute through the NIH extramural Loan Repayment Program | Professional/Scientific Organization | Member | External | National | 2006 | 2019 |
SPORE in Ovarian and Gynecological Cancer Review Committee | Study Section | chair and reviewer | External | National | 2005 | 2005 |
Program Committee, SGO Meeting | Professional/Scientific Organization | Member | External | National | 2004 | 2004 |
Scientific Advisory Board, Ovarian Cancer Research Fund, NY | Advisory Committee | Advisory Board | External | Local | 2004 | |
Gynecologic Cancer Research Applications | Professional/Scientific Organization | Department of Defense (DOD) Reviewer | National | 2004 | 2009 | |
National Institute of Health | Study Section | SBMI Medical Imaging Technologies Reviewer, | External | National | 2004 | 2010 |
Third AACR International Conference on Frontiers in Cancer Prevention Research | Professional/Scientific Organization | Member | External | International | 2004 | 2004 |
National Advisory Board for the Center for Gamma-Ray Imaging | Advisory Committee | Member | External | National | 2003 | |
Pennsylvania Department of Health, Cancer Prevention and Control Section, Technical Review Committee for Ovarian Cancer Research Applications | Professional/Scientific Organization | Member | External | State | 2003 | 2003 |
Society of Gynecologic Oncologist (SGO) | Professional/Scientific Organization | Member | External | National | 2002 | |
American Association for Cancer Research (AACR) | Professional/Scientific Organization | Member | External | National | 2002 | |
Southwest Oncology Group (SWOG) | Professional/Scientific Organization | Member | External | Regional | 2002 | 2006 |
United Engineering Foundation Conference, “Advances in Optics for Biotechnology, Medicine and Surgery”, August 3-8, 2003, Banff, Canada | Professional/Scientific Organization | Co-Chairman | External | National | 2002 | 2003 |
National Institutes of Health, National Cancer Institute (NIH/NCI), Reviewer for Gynecologic Cancer SPORE Applications | Professional/Scientific Organization | Member | External | National | 2002 | 2016 |
American Society of Clinical Oncology (ASCO) | Professional/Scientific Organization | Member | External | National | 2001 | |
Arizona Cancer Center | Professional/Scientific Organization | Member | External | State | 2001 | 2006 |
Gynecologic Cancer Applications | Study Section | Department of Energy (DOE) Reviewer, | External | National | 2001 | 2001 |
Taskforce on the Treatment of Intraepithelial Neoplasia, AACR Member, U.S. Food and Drug Administration (FDA) | Professional/Scientific Organization | Member | External | State | 2000 | 2000 |
Gynecologic Oncology Group (GOG) | Professional/Scientific Organization | Member | External | Local | 2000 | |
GOG Cancer Prevention and Control Committee | Professional/Scientific Organization | Member | External | National | 2000 | 2000 |
Academic Promotions Committee, SUNY | Education Committee | Member | External | University | 1987 | 1987 |
Not accepting students for lab rotations at this time
Journal Articles
-
Scar matrix drives Piezo1 mediated stromal inflammation leading to placenta accreta spectrum.
Nature communications 2024 Sep;15(1):8379
-
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer.
Scientific reports 2022 Nov;12(1):19936
-
Correction: Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell reports. Medicine 2020 Aug;1(5):
-
Proteogenomic Characterization of Ovarian HGSC Implicates Mitotic Kinases, Replication Stress in Observed Chromosomal Instability.
Cell reports. Medicine 2020 Apr;1(1):
-
Front-line chemo-immunotherapy with carboplatin-paclitaxel using oregovomab indirect immunization in advanced ovarian cancer: A randomized phase II study.
Gynecologic oncology 2020 Jan;
-
Sexual Health, Mental Health, and Beliefs About Cancer Treatments Among Women Attending a Gynecologic Oncology Clinic.
Sexual medicine 2017 Sep;5(3):e175-e183
-
Iron addiction: a novel therapeutic target in ovarian cancer.
Oncogene 2017 Mar;364089-4099
-
3D texture analysis for classification of second harmonic generation images of human ovarian cancer.
Scientific reports 2016 Oct;635734
-
Characterizing optical properties and spatial heterogeneity of human ovarian tissue using spatial frequency domain imaging.
Journal of biomedical optics 2016 Oct;21(10):101402
-
Coregistered photoacoustic and ultrasound imaging and classification of ovarian cancer: ex vivo and in vivo studies.
Journal of biomedical optics 2016 Apr;21(4):46006
-
Correlating optical coherence elastography based strain measurements with collagen content of the human ovarian tissue.
Biomedical optics express 2015 Oct;6(10):3806-11
-
In Vitro and In Vivo Correlates of Physiologic and Neoplastic Human Fallopian Tube Stem Cells.
The Journal of pathology 2015 Sep;238519-530
-
Inhibition of DNA methyltransferases, histone deacetylases and lysine-specific demethylase-1 suppresses the tumorigenicity of the ovarian cancer ascites cell line SKOV3.
International journal of oncology 2013 Aug;43(2):495-502
-
Anticancer efficacy of cisplatin and trichostatin A or 5-aza-2'-deoxycytidine on ovarian cancer.
British journal of cancer 2013 Feb;108(3):579-86
-
Quantitative analysis of estimated scattering coefficient and phase retardation for ovarian tissue characterization.
Biomedical optics express 2012 Jul;3(7):1548-56
-
Chemotherapy in pregnancy.
Clinical obstetrics and gynecology 2011 Dec;54(4):602-18
-
Optical scattering coefficient estimated by optical coherence tomography correlates with collagen content in ovarian tissue.
Journal of biomedical optics 2011 Sep;16(9):090504
-
Attitudes toward direct-to-consumer advertisements and online genetic testing among high-risk women participating in a hereditary cancer clinic.
Journal of health communication 2011 Jul;16(6):607-28
-
Potential role of coregistered photoacoustic and ultrasound imaging in ovarian cancer detection and characterization.
Translational oncology 2011 Jan;4(1):29-37
-
Alterations of the extracellular matrix in ovarian cancer studied by Second Harmonic Generation imaging microscopy.
BMC cancer 2010 Jan;1094
-
Laparoscopic optical coherence tomography imaging of human ovarian cancer.
Gynecologic oncology 2009 Aug;114(2):188-94
-
A prototype hybrid intraoperative probe for ovarian cancer detection.
Optics express 2009 Apr;17(9):7245-58
-
Ovarian neoplasm development by 7,12-dimethylbenz[a]anthracene (DMBA) in a chemically-induced rat model of ovarian failure.
Gynecologic oncology 2009 Mar;112(3):610-5
-
Endogenous optical biomarkers of ovarian cancer evaluated with multiphoton microscopy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007 Oct;16(10):2048-57
-
Complementary anti-cancer pathways triggered by inhibition of sideroflexin 4 in ovarian cancer.
.
Sci Rep. 2022 Nov 19;12(1):19936. doi:
Conference Papers
-
Endometrial Cancer: Is This a New Disease?Am Soc Clin Oncol Educ Book. 2017;37:435-442. doi: 10.14694/EDBK_175666.
2017 Jun;37435-442
-
Integrated optical coherence tomography, ultrasound and photoacoustic imaging for ovarian tissue characterization.
Biomedical optics express 2011 Sep;2(9):2551-61
-
Laparoscopic optical coherence tomographic imaging of human ovarian cancer
Proceedings of SPIE - The International Society for Optical Engineering 2009 Jan;7169
-
Photoacoustic characterization of ovarian tissue
Proceedings of SPIE - The International Society for Optical Engineering 2009 Jan;7177
-
Laparoscopic optical coherence tomographic imaging of human ovarian cancer
Progress in Biomedical Optics and Imaging - Proceedings of SPIE 2008 Jan;6851
-
Second harmonic generation imaging studies of diseased states
Microscopy and Microanalysis 2008 Jan;14(SUPPL. 2):736-737
Reviews
-
Endometrial cancer: a review and current management strategies: part II.
Gynecologic oncology 2014 Jun;134(2):393-402
-
Endometrial cancer: a review and current management strategies: part I.
Gynecologic oncology 2014 Jun;134(2):385-92
-
The potential of biologic network models in understanding the etiopathogenesis of ovarian cancer.
Gynecologic oncology 2010 Feb;116(2):282-5
Title or Abstract | Type | Sponsor/Event | Date/Year | Location |
---|---|---|---|---|
National Toxicity Program invited workshop attendee and invited presentation on ovarian cancer. | Talk | NTP and NIEHS | 2007 | |
Cervical intraepithelial lesions | Talk | International Symposium on Predictive Oncology and Therapy, Pasteur Institute | 2002 | Paris, France |
Optical imaging of the cervix | Talk | International Conference on Cervical Cancer | 2002 | Houston, Texas |
Epithelial ovarian cancer: Role of fluorescence spectroscopy | Talk | United Engineering Foundation | 2001 | Banff, Canada |
Prevention of ovarian cancer | Talk | Marriott Medical Center Hotel and The University of | 2000 | Houston, Texas |
Oral contraceptives and retinoids for ovarian cancer chemoprevention | Talk | University of Utah Health Science Center | 2000 | Salt Lake City, Utah |
New imaging modalities for ovarian cancer | Talk | Ovarian Cancer Research Fund | 2000 | New York, NY |
A review of the challenges in the prevention, progression and treatment of ovarian cancer | Talk | Joint Working Group on Quantitative In Vivo Functional Imaging in Oncology meeting | 1999 | Washington D.C. |
Update on chemotherapeutic treatment of ovarian dysgerminoma | Talk | American Radium Society | 1999 | |
Ovarian Cancer | Poster | National Cancer Institute, and the US Public Health Service's Office on Women's Health | 1999 | Washington, DC |
A system for rapid acquisition of excitation emission matrices in vivo: instruments and studies | Talk | The OSA Biomedical Topical meeting | 1998 |